Vann Equity Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$204K Buy
1,266
+30
+2% +$5K 0.12% 169
2026
Q2
$234K Buy
1,236
+16
+1% +$3.01K 0.14% 151
2026
Q1
$241K Buy
+1,220
New +$235K 0.17% 140

Other funds holding AZN

Vann Equity Management's AZN Position: Q3 2026 in Review

Vann Equity Management increased its AstraZeneca (AZN) stake by 2.4% in Q3 2026, buying an estimated $5K and bringing the position to 1,266 shares worth $204K. The position accounts for 0.12% of the portfolio, ranked #169.

Vann Equity Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $241K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Vann Equity Management held 1,266 shares of AstraZeneca worth $204K as of Q3 2026.
  • Vann Equity Management bought 30 AstraZeneca shares in Q3 2026, an estimated $5K.
  • AstraZeneca made up 0.12% of Vann Equity Management's portfolio in Q3 2026, its #169 holding.
  • Vann Equity Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • Vann Equity Management's AstraZeneca position peaked at $241K in Q1 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Vann Equity Management's 13F filing for Q3 2026, filed 8 Oct 2026.